Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients.

Magnussen GI, Hellesylt E, Nesland JM, Trope CG, Flørenes VA, Holm R.

BMC Cancer. 2013 Jun 14;13:288. doi: 10.1186/1471-2407-13-288.

PMID:
23767999
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma.

Vettukattil R, Hetland TE, Flørenes VA, Kærn J, Davidson B, Bathen TF.

Hum Pathol. 2013 Sep;44(9):1859-66. doi: 10.1016/j.humpath.2013.02.009. Epub 2013 May 6.

PMID:
23656974
[PubMed - indexed for MEDLINE]
3.

Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies.

Flatmark K, Guldvik IJ, Svensson H, Fleten KG, Flørenes VA, Reed W, Giercksky KE, Fodstad Ø, Andersson Y.

Int J Cancer. 2013 Sep 15;133(6):1497-506. doi: 10.1002/ijc.28158. Epub 2013 Apr 17.

PMID:
23494569
[PubMed - indexed for MEDLINE]
4.

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis.

Slipicevic A, Øy GF, Rosnes AK, Stakkestad Ø, Emilsen E, Engesæter B, Mælandsmo GM, Flørenes VA.

Cancer Biol Ther. 2013 Feb;14(2):146-54. doi: 10.4161/cbt.22953. Epub 2012 Nov 28.

PMID:
23192275
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance.

Hetland TE, Nymoen DA, Holth A, Brusegard K, Flørenes VA, Kærn J, Tropé CG, Davidson B.

Hum Pathol. 2013 May;44(5):777-85. doi: 10.1016/j.humpath.2012.08.002. Epub 2012 Oct 29.

PMID:
23114921
[PubMed - indexed for MEDLINE]
6.

Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma.

Engesæter B, Engebraaten O, Flørenes VA, Mælandsmo GM.

PLoS One. 2012;7(9):e45492. doi: 10.1371/journal.pone.0045492. Epub 2012 Sep 20.

PMID:
23029050
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.

Magnussen GI, Holm R, Emilsen E, Rosnes AK, Slipicevic A, Flørenes VA.

PLoS One. 2012;7(6):e38254. doi: 10.1371/journal.pone.0038254. Epub 2012 Jun 12.

PMID:
22719872
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival.

Hetland TE, Nymoen DA, Emilsen E, Kærn J, Tropé CG, Flørenes VA, Davidson B.

Gynecol Oncol. 2012 Sep;126(3):460-5. doi: 10.1016/j.ygyno.2012.05.029. Epub 2012 May 28.

PMID:
22652154
[PubMed - indexed for MEDLINE]
9.

HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases.

Hetland TE, Holth A, Kærn J, Flørenes VA, Tropé CG, Davidson B.

Virchows Arch. 2012 May;460(5):505-13. doi: 10.1007/s00428-012-1228-9. Epub 2012 Apr 4.

PMID:
22476403
[PubMed - indexed for MEDLINE]
10.

Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma.

Magnussen GI, Ree Rosnes AK, Shahzidi S, Dong HP, Emilsen E, Engesæter B, Flørenes VA.

Biochem Biophys Res Commun. 2012 Apr 13;420(3):516-22. doi: 10.1016/j.bbrc.2012.03.023. Epub 2012 Mar 13.

PMID:
22446330
[PubMed - indexed for MEDLINE]
11.

Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival.

Slipicevic A, Holm R, Emilsen E, Ree Rosnes AK, Welch DR, Mælandsmo GM, Flørenes VA.

BMC Cancer. 2012 Feb 22;12:73. doi: 10.1186/1471-2407-12-73.

PMID:
22356677
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index.

Hetland TE, Kærn J, Skrede M, Sandstad B, Tropé C, Davidson B, Flørenes VA.

Cancer Chemother Pharmacol. 2012 May;69(5):1307-14. doi: 10.1007/s00280-012-1835-9.

PMID:
22302409
[PubMed - indexed for MEDLINE]
13.

Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusions.

Dong HP, Ree Rosnes AK, Bock AJ, Holth A, Flørenes VA, Trope' CG, Risberg B, Davidson B.

Cytopathology. 2011 Dec;22(6):373-82. doi: 10.1111/j.1365-2303.2011.00929.x. Epub 2011 Oct 28.

PMID:
22032542
[PubMed - indexed for MEDLINE]
14.

Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.

Engesæter BO, Sathermugathevan M, Hellenes T, Engebråten O, Holm R, Flørenes VA, Mælandsmo GM.

Cancer Biol Ther. 2011 Jul 1;12(1):47-58. doi: 10.4161/cbt.12.1.15714. Epub 2011 Jul 1.

PMID:
21508672
[PubMed - indexed for MEDLINE]
Free Article
15.

Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.

Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J.

Hum Pathol. 2011 Jul;42(7):1019-26. doi: 10.1016/j.humpath.2010.10.025. Epub 2011 Feb 11.

PMID:
21315408
[PubMed - indexed for MEDLINE]
16.

Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.

Wang Z, Trope CG, Flørenes VA, Suo Z, Nesland JM, Holm R.

BMC Cancer. 2010 May 25;10:233. doi: 10.1186/1471-2407-10-233.

PMID:
20500813
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma.

Oy GF, Slipicevic A, Davidson B, Solberg Faye R, Maelandsmo GM, Flørenes VA.

Int J Cancer. 2010 Jan 15;126(2):350-61. doi: 10.1002/ijc.24727.

PMID:
19588500
[PubMed - indexed for MEDLINE]
18.

Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.

Maelandsmo GM, Flørenes VA, Nguyen MT, Flatmark K, Davidson B.

Tumour Biol. 2009;30(1):15-25. doi: 10.1159/000199447. Epub 2009 Feb 5.

PMID:
19194111
[PubMed - indexed for MEDLINE]
19.

Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.

Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B.

Hum Pathol. 2009 Jun;40(6):795-806. doi: 10.1016/j.humpath.2008.10.019. Epub 2009 Jan 20.

PMID:
19157506
[PubMed - indexed for MEDLINE]
20.

Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.

Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B.

Hum Pathol. 2009 Apr;40(4):527-37. doi: 10.1016/j.humpath.2008.10.003. Epub 2009 Jan 3.

PMID:
19121847
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk